approved EB-2 (NIW)

Senior Research Specialist

Biotechnology · India · 2025-05-31

Processing Time
515 days
Decision Date
2025-05-31
Location
Tennessee
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue his research in cell and molecular biology with a focus on yeast biotechnology to develop thermostable vaccines and investigate antifungal drug mechanisms. His work utilizes lyophilized yeast cells to stabilize vaccine proteins at room temperature, aiming to eliminate cold-chain requirements for global health and agricultural applications.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses critical issues in vaccine stability and antifungal resistance which have significant implications for U.S. healthcare and agriculture.

2 Well-positioned to Advance the Endeavor Met

The petitioner's extensive publication record, high citation count, and roles as a journal editor and grant reviewer demonstrate his leadership in the field.

3 Waiver of Job Offer and Labor Certification Met

The petitioner's unique expertise in yeast biotechnology provides a benefit to the U.S. that outweighs the need for a labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's 26 peer-reviewed publications and 594 citations. He demonstrated significant impact through 77 peer reviews and editorial roles for journals like PLOS ONE and Frontiers in Fungal Biology, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Reference Letters Dependent
Judging Experience
Original Contributions
Editorial Roles

Similar Cases

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
Pennsylvania 64 days 2025-11-26
The petitioner proposes to continue research on the fundamental mechanisms of cellular stress response and immune system function to advance vaccine development and biotherapeutics. The work utilizes antibody engineering and advanced sequencing technologies to create practical innovations for protecting vulnerable populations from respiratory infections. The intended impact is to address nationwide public health challenges and improve national health security through immediate therapeutic potential.

Postdoctoral Researcher

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Kentucky 5 days 2024-03-27
The petitioner proposes to continue his research in molecular microbiology, microbial biotechnology, and tissue engineering. His work focuses on using halophilic archaea for carotenoid production and optimizing extracellular polysaccharide applications for wound healing and cancer treatments. This research aims to enhance the bioactivity of herbal extracts and develop advanced biomaterials for therapeutic use.
WeGreened EB-2 (NIW) approved
Texas 26 days 2025-02-05
The petitioner proposes to continue investigating the molecular dynamics of viral replication and pathogenesis using model viral systems at a U.S. academic institution. This work focuses on exploring viral-host interactions and immune evasion strategies to facilitate the development of advanced vaccine platforms and targeted antiviral therapies. The endeavor aims to strengthen the United States' defense against viral epidemics and bioterrorism threats.

Clinical Researcher

Biotechnology

WeGreened EB-2 (NIW) approved
602 days 2025-09-18
The petitioner proposes to develop innovative clinical trial methodologies to evaluate new treatments, vaccines, and medical devices. This work focuses on optimizing health outcomes and improving patient diagnosis through efficient testing of emerging medical technologies.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-05-31.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 515 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist